The Personalized Medicine Outsourcing Market was valued at USD 109.88 billion in 2024, expected to reach USD 281.72 billion by 2032. The US market was worth USD 30.61 billion in 2024, projected to hit USD 77.07 billion in 2032. North America leads due to strong healthcare infrastructure and R&D investment. Biopharma companies are partnering with CROs, CDMOs, and diagnostic service providers to cut costs and time in research and development.
In 2024, the clinical phase segment held the largest market share at 66.41%, with the preclinical segment expected to grow rapidly. Oncology accounted for 55.2% market share, with rare diseases anticipated to see significant growth. Contract manufacturing is the largest segment, with contract development expected to grow the fastest due to the complexity of personalized medicine development.
Inhibitor pharmaceuticals dominated the market in 2024, with cell & gene therapy poised for rapid growth. North America holds a 36.6% market share, driven by its healthcare infrastructure and regulatory frameworks. Asia Pacific is expected to be the fastest-growing region due to increased healthcare expenditure and clinical trial activities. Major players in the market include Aurigene Pharmaceutical Services, Syngene, Syneos Health, and more. The Personalized Medicine Outsourcing Market is projected to reach USD 109.88 billion by 2024 and USD 281.72 billion by 2032, with a CAGR of 12.54% from 2025 to 2032. Key segments include product, application, service, type, and end use. Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
For more details on the Personalized Medicine Outsourcing Market Analysis & Outlook, visit https://www.snsinsider.com/reports/personalized-medicine-outsourcing-market-8194. SNS Insider is a leading market research and consulting agency providing clients with current, accurate market data and insights to make confident decisions in changing circumstances. Contact us at [email protected] for customized research.
Read more at GlobeNewswire: Personalized Medicine Outsourcing Market to Reach USD